<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-12-01" modified="2017-05-10" version="187">
<accession>P29322</accession>
<accession>Q6IN80</accession>
<accession>Q8IUX6</accession>
<accession>Q9NUA9</accession>
<accession>Q9P269</accession>
<name>EPHA8_HUMAN</name>
<protein>
<recommendedName>
<fullName>Ephrin type-A receptor 8</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>EPH- and ELK-related kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>EPH-like kinase 3</fullName>
<shortName>EK3</shortName>
<shortName>hEK3</shortName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase receptor EEK</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">EPHA8</name>
<name type="synonym">EEK</name>
<name type="synonym">HEK3</name>
<name type="synonym">KIAA1459</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Eye</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2000" name="DNA Res." volume="7" first="143" last="150">
<title>Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Kikuno R."/>
<person name="Ishikawa K."/>
<person name="Hirosawa M."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="10819331"/>
<dbReference type="DOI" id="10.1093/dnares/7.2.143"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 153-1005 (ISOFORM 1)</scope>
<scope>VARIANT GLN-612</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1991" name="Oncogene" volume="6" first="1057" last="1061">
<title>eek and erk, new members of the eph subclass of receptor protein-tyrosine kinases.</title>
<authorList>
<person name="Chan J."/>
<person name="Watt V.M."/>
</authorList>
<dbReference type="PubMed" id="1648701"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 706-726</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="Cell" volume="90" first="403" last="404">
<title>Unified nomenclature for Eph family receptors and their ligands, the ephrins.</title>
<authorList>
<consortium name="Eph nomenclature committee"/>
</authorList>
<dbReference type="PubMed" id="9267020"/>
</citation>
<scope>NOMENCLATURE</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="5413" last="5422">
<title>Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn binding to the Tyr-615 site by enhancing tyrosine kinase activity.</title>
<authorList>
<person name="Choi S."/>
<person name="Park S."/>
</authorList>
<dbReference type="PubMed" id="10498895"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202917"/>
</citation>
<scope>INTERACTION WITH FYN</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="4579" last="4597">
<title>The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner.</title>
<authorList>
<person name="Gu C."/>
<person name="Park S."/>
</authorList>
<dbReference type="PubMed" id="11416136"/>
<dbReference type="DOI" id="10.1128/MCB.21.14.4579-4597.2001"/>
</citation>
<scope>INTERACTION WITH PIK3CG</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="8113" last="8126">
<title>Identification of phosphotyrosine binding domain-containing proteins as novel downstream targets of the EphA8 signaling function.</title>
<authorList>
<person name="Shin J."/>
<person name="Gu C."/>
<person name="Park E."/>
<person name="Park S."/>
</authorList>
<dbReference type="PubMed" id="17875921"/>
<dbReference type="DOI" id="10.1128/MCB.00794-07"/>
</citation>
<scope>INTERACTION WITH ANKS1B</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2010" name="Mol. Cells" volume="29" first="603" last="609">
<title>EphA8-ephrinA5 signaling and clathrin-mediated endocytosis is regulated by Tiam-1, a Rac-specific guanine nucleotide exchange factor.</title>
<authorList>
<person name="Yoo S."/>
<person name="Shin J."/>
<person name="Park S."/>
</authorList>
<dbReference type="PubMed" id="20496116"/>
<dbReference type="DOI" id="10.1007/s10059-010-0075-2"/>
</citation>
<scope>INTERACTION WITH TIAM1</scope>
</reference>
<reference key="10">
<citation type="submission" date="2005-11" db="PDB data bank">
<title>Solution structure of the second FN3 domain and of sterile alpha motif (SAM) domain of EPH receptor A8 protein.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 437-534 AND 932-1000</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] SER-45; LEU-60; LYS-123; CYS-179; LEU-198 AND LEU-860</scope>
</reference>
<comment type="function">
<text evidence="4">Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. The GPI-anchored ephrin-A EFNA2, EFNA3, and EFNA5 are able to activate EPHA8 through phosphorylation. With EFNA5 may regulate integrin-mediated cell adhesion and migration on fibronectin substrate but also neurite outgrowth. During development of the nervous system plays also a role in axon guidance. Downstream effectors of the EPHA8 signaling pathway include FYN which promotes cell adhesion upon activation by EPHA8 and the MAP kinases in the stimulation of neurite outgrowth (By similarity).</text>
</comment>
<comment type="catalytic activity">
<text evidence="11">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="subunit">
<text evidence="4 12 14 16 17">Heterotetramer upon binding of the ligand. The heterotetramer is composed of an ephrin dimer and a receptor dimer. Oligomerization is probably required to induce biological responses. May also form heterodimers with other ephrin receptors (By similarity). Interacts with FYN; possible downstream effector of EPHA8 in regulation of cell adhesion. Interacts with PIK3CG; regulates integrin-mediated cell adhesion to substrate. Interacts with TIAM1; regulates clathrin-mediated endocytosis of EPHA8. Interacts with ANKS1A and ANKS1B; EPHA8 kinase activity-independent but stimulated by EPHA8 ubiquitination.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="5">Cell membrane</location>
<topology evidence="6">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Cell projection</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Early endosome membrane</location>
</subcellularLocation>
<text evidence="5">Undergoes clathrin-mediated endocytosis upon EFNA5-binding and is targeted to early endosomes.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P29322-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P29322-2</id>
<name>2</name>
<sequence type="described" ref="VSP_041946 VSP_041947"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="PTM">
<text evidence="4">Phosphorylated. Phosphorylation is stimulated upon binding of its ligands including EFNA2, EFNA3 and EFNA5. Autophosphorylation on Tyr-616 is critical for association with FYN. Autophosphorylation on Tyr-839 modulates tyrosine kinase activity (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="4">Ubiquitinated. Ubiquitination by CBL regulates the receptor stability and activity through proteasomal degradation. ANKS1A prevents ubiquitination and degradation (By similarity).</text>
</comment>
<comment type="similarity">
<text evidence="7">Belongs to the protein kinase superfamily. Tyr protein kinase family. Ephrin receptor subfamily.</text>
</comment>
<comment type="sequence caution" evidence="19">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="CAA41980" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="AL035703">
<property type="protein sequence ID" value="CAB81612.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL035703">
<property type="protein sequence ID" value="CAI22039.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC038796">
<property type="protein sequence ID" value="AAH38796.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC072417">
<property type="protein sequence ID" value="AAH72417.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB040892">
<property type="protein sequence ID" value="BAA95983.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X59291">
<property type="protein sequence ID" value="CAA41980.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS225.1">
<molecule id="P29322-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30626.1">
<molecule id="P29322-2"/>
</dbReference>
<dbReference type="PIR" id="S23361">
<property type="entry name" value="S23361"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001006944.1">
<molecule id="P29322-2"/>
<property type="nucleotide sequence ID" value="NM_001006943.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_065387.1">
<molecule id="P29322-1"/>
<property type="nucleotide sequence ID" value="NM_020526.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.283613"/>
<dbReference type="PDB" id="1UCV">
<property type="method" value="NMR"/>
<property type="chains" value="A=933-1000"/>
</dbReference>
<dbReference type="PDB" id="1X5L">
<property type="method" value="NMR"/>
<property type="chains" value="A=437-534"/>
</dbReference>
<dbReference type="PDB" id="3KUL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A/B=602-909"/>
</dbReference>
<dbReference type="PDBsum" id="1UCV"/>
<dbReference type="PDBsum" id="1X5L"/>
<dbReference type="PDBsum" id="3KUL"/>
<dbReference type="ProteinModelPortal" id="P29322"/>
<dbReference type="SMR" id="P29322"/>
<dbReference type="BioGrid" id="108360">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="IntAct" id="P29322">
<property type="interactions" value="7"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000166244"/>
<dbReference type="BindingDB" id="P29322"/>
<dbReference type="ChEMBL" id="CHEMBL4134"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1828"/>
<dbReference type="iPTMnet" id="P29322"/>
<dbReference type="PhosphoSitePlus" id="P29322"/>
<dbReference type="BioMuta" id="EPHA8"/>
<dbReference type="DMDM" id="19857975"/>
<dbReference type="EPD" id="P29322"/>
<dbReference type="MaxQB" id="P29322"/>
<dbReference type="PaxDb" id="P29322"/>
<dbReference type="PeptideAtlas" id="P29322"/>
<dbReference type="PRIDE" id="P29322"/>
<dbReference type="DNASU" id="2046"/>
<dbReference type="Ensembl" id="ENST00000166244">
<molecule id="P29322-1"/>
<property type="protein sequence ID" value="ENSP00000166244"/>
<property type="gene ID" value="ENSG00000070886"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000374644">
<molecule id="P29322-2"/>
<property type="protein sequence ID" value="ENSP00000363775"/>
<property type="gene ID" value="ENSG00000070886"/>
</dbReference>
<dbReference type="GeneID" id="2046"/>
<dbReference type="KEGG" id="hsa:2046"/>
<dbReference type="UCSC" id="uc001bfw.4">
<molecule id="P29322-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2046"/>
<dbReference type="DisGeNET" id="2046"/>
<dbReference type="GeneCards" id="EPHA8"/>
<dbReference type="HGNC" id="HGNC:3391">
<property type="gene designation" value="EPHA8"/>
</dbReference>
<dbReference type="HPA" id="CAB009660"/>
<dbReference type="HPA" id="HPA031433"/>
<dbReference type="MIM" id="176945">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P29322"/>
<dbReference type="OpenTargets" id="ENSG00000070886"/>
<dbReference type="PharmGKB" id="PA27823"/>
<dbReference type="eggNOG" id="KOG0196">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118975"/>
<dbReference type="HOGENOM" id="HOG000233856"/>
<dbReference type="HOVERGEN" id="HBG062180"/>
<dbReference type="InParanoid" id="P29322"/>
<dbReference type="KO" id="K05109"/>
<dbReference type="OMA" id="EPHNYEE"/>
<dbReference type="OrthoDB" id="EOG091G00W0"/>
<dbReference type="PhylomeDB" id="P29322"/>
<dbReference type="TreeFam" id="TF315608"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2682334">
<property type="pathway name" value="EPH-Ephrin signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928663">
<property type="pathway name" value="EPHA-mediated growth cone collapse"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928665">
<property type="pathway name" value="EPH-ephrin mediated repulsion of cells"/>
</dbReference>
<dbReference type="SignaLink" id="P29322"/>
<dbReference type="SIGNOR" id="P29322"/>
<dbReference type="EvolutionaryTrace" id="P29322"/>
<dbReference type="GeneWiki" id="EPHA8"/>
<dbReference type="GenomeRNAi" id="2046"/>
<dbReference type="PRO" id="PR:P29322"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000070886"/>
<dbReference type="CleanEx" id="HS_EPHA8"/>
<dbReference type="Genevisible" id="P29322">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031901">
<property type="term" value="C:early endosome membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005004">
<property type="term" value="F:GPI-linked ephrin receptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007155">
<property type="term" value="P:cell adhesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0071372">
<property type="term" value="P:cellular response to follicle-stimulating hormone stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048013">
<property type="term" value="P:ephrin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031175">
<property type="term" value="P:neuron projection development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016322">
<property type="term" value="P:neuron remodeling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043552">
<property type="term" value="P:positive regulation of phosphatidylinositol 3-kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030155">
<property type="term" value="P:regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033628">
<property type="term" value="P:regulation of cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006929">
<property type="term" value="P:substrate-dependent cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00063">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.120.260">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR027936">
<property type="entry name" value="Eph_TM"/>
</dbReference>
<dbReference type="InterPro" id="IPR001090">
<property type="entry name" value="Ephrin_rcpt_lig-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR020691">
<property type="entry name" value="EphrinA_rcpt8"/>
</dbReference>
<dbReference type="InterPro" id="IPR003961">
<property type="entry name" value="FN3_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008979">
<property type="entry name" value="Galactose-bd-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001660">
<property type="entry name" value="SAM"/>
</dbReference>
<dbReference type="InterPro" id="IPR013761">
<property type="entry name" value="SAM/pointed"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011641">
<property type="entry name" value="Tyr-kin_ephrin_A/B_rcpt-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016257">
<property type="entry name" value="Tyr_kinase_ephrin_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001426">
<property type="entry name" value="Tyr_kinase_rcpt_V_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR24416:SF476">
<property type="entry name" value="PTHR24416:SF476"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14575">
<property type="entry name" value="EphA2_TM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01404">
<property type="entry name" value="Ephrin_lbd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00041">
<property type="entry name" value="fn3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00536">
<property type="entry name" value="SAM_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000666">
<property type="entry name" value="TyrPK_ephrin_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00615">
<property type="entry name" value="EPH_lbd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01411">
<property type="entry name" value="Ephrin_rec_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00060">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00454">
<property type="entry name" value="SAM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47769">
<property type="entry name" value="SSF47769"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49265">
<property type="entry name" value="SSF49265"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49785">
<property type="entry name" value="SSF49785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01186">
<property type="entry name" value="EGF_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51550">
<property type="entry name" value="EPH_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50853">
<property type="entry name" value="FN3"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00790">
<property type="entry name" value="RECEPTOR_TYR_KIN_V_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00791">
<property type="entry name" value="RECEPTOR_TYR_KIN_V_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50105">
<property type="entry name" value="SAM_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="6">
<location>
<begin position="1"/>
<end position="27"/>
</location>
</feature>
<feature type="chain" description="Ephrin type-A receptor 8" id="PRO_0000016822">
<location>
<begin position="28"/>
<end position="1005"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="6">
<location>
<begin position="28"/>
<end position="542"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="6">
<location>
<begin position="543"/>
<end position="563"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="6">
<location>
<begin position="564"/>
<end position="1005"/>
</location>
</feature>
<feature type="domain" description="Eph LBD" evidence="10">
<location>
<begin position="31"/>
<end position="209"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 1" evidence="9">
<location>
<begin position="328"/>
<end position="438"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 2" evidence="9">
<location>
<begin position="439"/>
<end position="534"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="7">
<location>
<begin position="635"/>
<end position="896"/>
</location>
</feature>
<feature type="domain" description="SAM" evidence="8">
<location>
<begin position="930"/>
<end position="994"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="7">
<location>
<begin position="641"/>
<end position="649"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with ANKS1A and ANKS1B" evidence="4">
<location>
<begin position="564"/>
<end position="570"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with PIK3CG and required for endocytosis" evidence="4">
<location>
<begin position="589"/>
<end position="644"/>
</location>
</feature>
<feature type="short sequence motif" description="PDZ-binding" evidence="6">
<location>
<begin position="1003"/>
<end position="1005"/>
</location>
</feature>
<feature type="compositionally biased region" description="Cys-rich">
<location>
<begin position="191"/>
<end position="325"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="7 11">
<location>
<position position="760"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="7">
<location>
<position position="667"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="4">
<location>
<position position="616"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="4">
<location>
<position position="839"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="340"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="407"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="6">
<location>
<position position="432"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_041946" evidence="18">
<original>APSQVVVIRQERAGQTSVSLLWQEPEQPNGIILEYEIKYYEKDKEMQSYSTLKAVTT</original>
<variation>GRRRNSVPQRPGPPASPASDPSRDQSSAGDVLWAFRQVPLWPCAPHQDPELEALHCL</variation>
<location>
<begin position="439"/>
<end position="495"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_041947" evidence="18">
<location>
<begin position="496"/>
<end position="1005"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45498698." id="VAR_042153" evidence="15">
<original>G</original>
<variation>S</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56402644." id="VAR_042154" evidence="15">
<original>V</original>
<variation>L</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast infiltrating ductal carcinoma sample; somatic mutation." id="VAR_042155" evidence="15">
<original>N</original>
<variation>K</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In a gastric adenocarcinoma sample; somatic mutation." id="VAR_042156" evidence="15">
<original>R</original>
<variation>C</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma sample; somatic mutation." id="VAR_042157" evidence="15">
<original>R</original>
<variation>L</variation>
<location>
<position position="198"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56656925." id="VAR_061292">
<original>P</original>
<variation>L</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2295021." id="VAR_022107">
<original>V</original>
<variation>M</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs999765." id="VAR_024514" evidence="13">
<original>E</original>
<variation>Q</variation>
<location>
<position position="612"/>
</location>
</feature>
<feature type="sequence variant" description="In a metastatic melanoma sample; somatic mutation." id="VAR_042158" evidence="15">
<original>P</original>
<variation>L</variation>
<location>
<position position="860"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAA95983." ref="3" evidence="19">
<original>S</original>
<variation>L</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="456"/>
<end position="460"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="472"/>
<end position="482"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="488"/>
<end position="499"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="507"/>
<end position="510"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="512"/>
<end position="516"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="527"/>
<end position="530"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="632"/>
<end position="634"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="635"/>
<end position="643"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="644"/>
<end position="646"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="647"/>
<end position="654"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="662"/>
<end position="669"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="675"/>
<end position="688"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="699"/>
<end position="703"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="705"/>
<end position="707"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="710"/>
<end position="714"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="721"/>
<end position="726"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="727"/>
<end position="730"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="734"/>
<end position="753"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="763"/>
<end position="765"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="766"/>
<end position="768"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="774"/>
<end position="776"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="802"/>
<end position="804"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="807"/>
<end position="812"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="817"/>
<end position="832"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="833"/>
<end position="835"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="838"/>
<end position="841"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="844"/>
<end position="852"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="865"/>
<end position="874"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="879"/>
<end position="881"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="885"/>
<end position="897"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="935"/>
<end position="941"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="945"/>
<end position="947"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="948"/>
<end position="953"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="959"/>
<end position="962"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="967"/>
<end position="973"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="978"/>
<end position="995"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1UCV"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1X5L"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KUL"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O09127"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255"/>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00184"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00316"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00883"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10498895"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10819331"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11416136"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17875921"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20496116"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000305"/>
<sequence length="1005" mass="111003" checksum="6FBF85535E4212B3" modified="2001-10-18" version="2" precursor="true">
MAPARGRLPPALWVVTAAAAAATCVSAARGEVNLLDTSTIHGDWGWLTYPAHGWDSINEV
DESFQPIHTYQVCNVMSPNQNNWLRTSWVPRDGARRVYAEIKFTLRDCNSMPGVLGTCKE
TFNLYYLESDRDLGASTQESQFLKIDTIAADESFTGADLGVRRLKLNTEVRSVGPLSKRG
FYLAFQDIGACLAILSLRIYYKKCPAMVRNLAAFSEAVTGADSSSLVEVRGQCVRHSEER
DTPKMYCSAEGEWLVPIGKCVCSAGYEERRDACVACELGFYKSAPGDQLCARCPPHSHSA
APAAQACHCDLSYYRAALDPPSSACTRPPSAPVNLISSVNGTSVTLEWAPPLDPGGRSDI
TYNAVCRRCPWALSRCEACGSGTRFVPQQTSLVQASLLVANLLAHMNYSFWIEAVNGVSD
LSPEPRRAAVVNITTNQAAPSQVVVIRQERAGQTSVSLLWQEPEQPNGIILEYEIKYYEK
DKEMQSYSTLKAVTTRATVSGLKPGTRYVFQVRARTSAGCGRFSQAMEVETGKPRPRYDT
RTIVWICLTLITGLVVLLLLLICKKRHCGYSKAFQDSDEEKMHYQNGQAPPPVFLPLHHP
PGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR
DVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGS
LDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFG
LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW
NMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE
SLRATATVSRCPPPAFVRSCFDLRGGSGGGGGLTVGDWLDSIRMGRYRDHFAAGGYSSLG
MVLRMNAQDVRALGITLMGHQKKILGSIQTMRAQLTSTQGPRRHL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>